It takes two to Tan­go: The biotech us­ing CRISPR to dis­cov­er new can­cer gene tar­gets rides a $353M SPAC deal to Nas­daq

5 years ago
Financing

An­ti-ag­ing biotech up­start plucks a drug from Am­gen's dis­card pile, piv­ot­ing from heart fail­ure to mus­cle con­di­tions

5 years ago
Deals

For­mer head of FDA’s med­ical and sci­en­tif­ic af­fairs on Covid: ‘FDA has nev­er been test­ed like this’

5 years ago
People
FDA+

Eli Lil­ly seeds a well-con­nect­ed Chi­na neu­ro start­up with drugs aim­ing at where Bio­gen, Voy­ager missed

5 years ago
Deals
China

'Learned a lot last year': Af­ter Covid-19 suc­cess, Mod­er­na's Stéphane Ban­cel plans to give rest of pipeline a big ...

5 years ago
R&D

Af­ter be­ing goad­ed to sell the com­pa­ny, Alex­ion's CEO set some am­bi­tious new goals for in­vestors. Then Pas­cal So­ri­ot ...

5 years ago
Deals

Mod­er­na says Covid-19 boost­ers stand a fight­ing chance against new vari­ants

5 years ago
R&D
Coronavirus

Pankaj Bhar­ga­va was a cen­tral fig­ure in the group fash­ion­ing Gilead’s on­col­o­gy strat­e­gy. Now he’s jumped to the ...

5 years ago
People

Fifth Cir­cuit sides with FTC in ma­jor pay-for-de­lay set­tle­ment case

5 years ago
Pharma
FDA+

Opin­ion: Biden needs to step up and nom­i­nate an FDA com­mis­sion­er

5 years ago
FDA+
Opinion

Tu­mor-treat­ing elec­tric fields show ear­ly promise in NSCLC — boost­ing both Novo­cure and its Chi­nese biotech part­ner

5 years ago
R&D

Re­cur­sion lays out $300M+ goal in IPO terms; Evotec and Bris­tol My­ers team up to spin out Ger­man re­search

5 years ago
News Briefing

FDA dis­pens­es with in-per­son re­quire­ment for abor­tion pill ac­cess dur­ing the pan­dem­ic

5 years ago
Pharma
FDA+

Tim Lu’s gene-cir­cuit star Sen­ti signs up for a $645M dis­cov­ery al­liance with Roche sub Spark

5 years ago
Deals

Bain dou­bles down on Tony Coles’ quest to get a late-stage Parkin­son’s drug through to mar­ket

5 years ago
Financing
R&D

Jaguar, Sean Nolan's lat­est biotech, rais­es $139M as they fol­low Taysha's foot­steps

5 years ago
Financing

Neil Ku­mar's Bridge­Bio finds 7 new aca­d­e­m­ic part­ners to join the fight against ge­net­ic dis­ease

5 years ago
Deals

Covid-19 roundup: Cit­ing a lack of need, Gilead cuts remde­sivir study; No­vavax vac­cine pro­duc­tion slowed due to ...

5 years ago
Coronavirus

Toad ven­om to treat de­pres­sion? RA Cap­i­tal wa­gers $125M on lat­est psy­che­del­ic biotech

5 years ago
Financing

Amarin CEO John Thero pass­es ba­ton to Eu­rope com­mer­cial chief as M&A hopes con­tin­ue to de­flate

5 years ago
People

Ar­cel­lx rais­es mega-round to put con­trol­lable CAR-T in­to the clin­ic

5 years ago
Financing
R&D

J&J paus­es vac­cine roll­out as feds probe rare cas­es of blood clots

5 years ago
FDA+
Coronavirus

Or­biMed-backed The­seus de­buts with $100M round in hero­ic quest for 'pan-vari­ant' ki­nase in­hibitors

5 years ago
Financing
R&D

In­vestors throw $189M at Flag­ship star­tup's mis­sion to 'de­code' in­ter­ac­tions be­tween T cells and anti­gens

5 years ago
Financing
First page Previous page 708709710711712713714 Next page Last page
A service from the Financial Times